Academic industry relationships in biotechnology: A primer on policy and practice

Cloning

Volumn 2, Issue 3, 2000, Pages 129-136

  Campbell, Eric G ^a,c   Blumenthal, David ^b,d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Department of Health Care Policy ^*  (United States)

^d Medicine Institute for Health Policy   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECHNOLOGY; ECONOMIC ASPECT; GENE TECHNOLOGY; GOVERNMENT; INDUSTRY; MANAGEMENT; MEDICAL RESEARCH; POLICY; PRIORITY JOURNAL; PUBLIC OPINION; REVIEW; SOCIAL ASPECT;

ANIMALS; BIOLOGICAL SCIENCES; BIOMEDICAL RESEARCH; BIOTECHNOLOGY; CONFLICT OF INTEREST; GENETICS; HUMANS; INDUSTRY; INTERINSTITUTIONAL RELATIONS; PUBLIC POLICY; RESEARCH SUPPORT; UNIVERSITIES;

EID: 0033680089     PISSN: 15204553     EISSN: None     Source Type: Journal    
DOI: 10.1089/152045500750039833     Document Type: Review

References (18)

1. Blumenthal, D. (1992). Academic-industry research relationships in the life sciences: Extent, consequences and management. JAMA 268(23), 3334-3339.
2. Blumenthal, D. (1999). Unpublished results from a 1995 survey of life science faculty.
3. Blumenthal, D., Campbell, E.G., Causino, N., and Louis, K.S. (1996a). Participation of life-science faculty in research relationships with industry. N. Engl. J. Med. 335(23), 1734-1739.
4. Blumenthal, D., Causino, N., Campbell, E.G., and Louis, K.S. (1996b). Relationships between academic institutions and industry in the life sciences: An industry survey. N. Engl. J. Med. 334(6), 368-373.
5. Blumenthal, D., Causino, N., and Campbell, E.G. (1997). Academic industry research relationships in genetics: A field apart. Nat. Genet. 16,104-108.
6. Blumenthal, D., Epstein, S., and Maxwell, J. (1986a). Commercializing university research: Lessons from the experiences of the Wisconsin Alumni Research Foundation. N. Engl. J. Med. 314:1621-1626.
7. Blumenthal, D., Gluck, M., Louis, K.S., Stoto, M.A., and Wise, M. (1986b). University-industry research relationships in the biotechnology: implications for the university. Science 232,1361-1366.
8. Bowie, N. (1994). University-business partnerships: An assessment. (Rowan & Littlefield Publishers, Inc., Lanham, MD).
9. Fox, M.F. (1985). Publication, performance and reward in science and scholarship. In Higher Education: Handbook of Theory and Research. J.C. Smart, ed. (Agathon Press, Edison, NJ) pp. 255-282.
10. Gluck, M., Bluinenthal, D., and Stoto, MA. (1987). University-relationships in the life sciences: Implications for students and post-doctoral fellows. Research Policy 16, 327-366.
11. Healy, B. (1993). The Dingell hearings on scientific misconduct: Blunt instruments needed. N. Engl. J. Med. 329(10), 725-727.
12. Hotz, R.L. (1999). Secrecy is often the price of medical research funding; Science: corporate donors and the academic community increasingly are at odds over the release of research findings. Los Angeles Times, May 18, Al.
13. Kenney, M. (1988). Biotechnology: The University-Industry Complex. (Yale University Press, New Haven, CT).
14. Lau, E. (1999). Corporate dollars cause stir among scientists. Washington Times, September 12, D2.
15. Saltus, R. (1998). Corporate gifts raise issue of objectivity. Boston Globe, April l, A6.
16. Stelfox, H.T., Chula, G., O'Rourke, K., and Detsky, A.S. (1998). Conflict of interest in the debate over calciumchannel antagonists. N. Engl. J. Med. 339(2), 101-106.
17. Stolberg, C.G. (1998). Gifts to science researchers have strings. The New York Times, April l, A17.
18. Swan, J.P. (1988). Academic Scientists and the Pharmaceutical Industry. (The Johns Hopkins University Press, Baltimore, MD).